chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The patient came in with sibling and father on 9/26/22. I Verified with Patients father that the patients would be receiving the first booster for covid-19 vaccination. I made him aware of the vaccination details "they'll be receiving the first booster for pfizer ages 5-11 years old. They will have to wait  15 minutes after they receive the booster to make sure there are no adverse effects" The father agreed, and handed me the covid 19 vaccine cards (with only the first and second administered covid 19 vaccines visible) . After that I  administered the vaccine and the patient, when I came back to  my desk to update the vaccine cards I noticed a second card in the back of the first one which had the booster information on it.
Janssen COVID-19 Vaccine: patient presents to clinic six days after vaccination reporting fever, elevated blood pressure, blistering rash from chin to toes, muscle cramping, and disequilibrium starting soon after immunization. Vital signs within normal ranges. Patient referred to emergency department (ED) immediately.
She took the dose twice, Nurse gave the first dose to the patient, and accidentaly the second nurse with second nurse from the facility from pharmacy team gave the second dose to her
Tooth filling came out; pain at that tooth when eating; This spontaneous case was reported by a consumer and describes the occurrence of TOOTH FRACTURE (Tooth filling came out) and TOOTHACHE (pain at that tooth when eating) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced TOOTH FRACTURE (Tooth filling came out) and TOOTHACHE (pain at that tooth when eating). At the time of the report, TOOTH FRACTURE (Tooth filling came out) and TOOTHACHE (pain at that tooth when eating) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
More tender injections site; Tiredness; Chills; Body aches; Fever of 100; Nausea; Feeling unwell; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 27Apr2021 at 12:00 at the age of 56-years-old as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included unspecified antibiotic, taken for an unspecified indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 05Apr2021 at 16:00 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. On 28Apr2021 at 02:00, in regards to the second shot, 14 hours after the injection, the patient experienced more tender injection site, tiredness, chills, body aches, fever of 100 (unspecified units), nausea, and feeling unwell which had lasted for 12 hours. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events more tender injection site, tiredness, chills, body aches, fever of 100, nausea, and feeling unwell was resolved on 28Apr2021.  No follow-up attempts are required, information about lot/batch number cannot be obtained. No further information is expected.
He got his COVID vaccines in 2021, but then had a bone marrow transplant; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 61-year-old male patient received BNT162b2 (BNT162B2), on 11Nov2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 59 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162b2 (DOSE 1, SINGLE), administration date: 03Feb2021, when the patient was 58-year-old, for COVID-19 immunisation; BNT162b2 (DOSE 2, SINGLE), administration date: 24Feb2021, when the patient was 58-year-old, for COVID-19 immunisation. The following information was reported: BONE MARROW TRANSPLANT (medically significant) with onset 2021, outcome "unknown", described as "He got his COVID vaccines in 2021, but then had a bone marrow transplant".  Clinical course: The reporter is vaccine coordinator reporting for office in general and stated that patient got his COVID vaccines in 2021, but then had a bone marrow transplant and had to get revaccinated. Patient had other conditions, but the reporter has no other details about his bone marrow transplant or other medical history for patient. This report is not related to a study or programme.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
ACUTE RESPIRATORY FAILURE 6/30/2022 CHOLEDOCHOLITHIASIS ACUTE HYPOXEMIC RESPIRATORY FAILURE 6/30/2022 CHOLEDOCHOLITHIASIS ACUTE RESPIRATORY FAILURE 6/30/2022 CKD STAGE 3A (GFR 45-59) ACUTE HYPOXEMIC RESPIRATORY FAILURE 6/30/2022 CKD STAGE 3A (GFR 45-59)
Woke up this morning around 5:30 with chills, could not get warm, took temperature around 6:30-100.4, right side of the throat is slightly scratchy, took temperature again at 7:15am- 99.7, feel very flushed and warm, starting drinking water and took Tylenol
positive COVID-19 test; positive COVID-19 test; cold; This is a spontaneous report from A contactable consumer reported for himself that a 70-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), first dose on 16Jan2021 and second dose on 04Feb2021, both via unspecified route of administration at single dose for COVID-19 immunization. Medical history included he was a smoker. Concomitant medications were not reported. Patient stated that prior to him getting his vaccine his wife tested positive, he tested negative so he went and got the 1st dose on 16Jan2021 and then on 04Feb2021 he got the 2nd dose. With the 1st dose he had hard side effects and then after the 2nd dose he got a cold in Feb2021, but then on 09Feb2021 he tested positive for COVID. He said after he tested positive he had nothing from the actual COVID so he wanted to call and say the vaccine works. Outcome of the events was unknown.  Information on the lot/batch number has been requested.
Parent called approx 1 hour after the Hep A vaccine was administered in the (L) arm. States pt had a rash on both arms, base of neck and upper chest. The vaccine was painful at administration. The rash was itchy. Today mom described the rash as hives.
Puffy eyes developed overnight the night after vaccine administered.  Benadryl no help. Continued to wake with puffy eyes for a few mornings. 2/27/12 seen by MD for a fine erythematous maculopapular rash which developed on extremities and trunk.  Rash faded but thereafter would recur with exertion.  Eye swelling became more prominent even into the evening.  Seen by MD again 3/2/12 for periorbital edema.  Urine dip was neg except for trace blood.  Suspected post-streptococcal glomerulonephritis.  Throat culture was positive for group A strep and patient was treated with Amoxicillin starting on 3/4/12.  Other bloodwork was negative at the time except for AST 62 and ALT 77.  Eye swelling persisited and was referred to allergist.  Her angioedema was thought to be post-viral.  A urine dip showed trace blood, trace protein and 2+ bilirubin.  Treated with 9 day steroid taper, after which angioedema never recurred.  On 3/7/12, AST 216, ALT 260.  By 3/16/12, AST 24, ALT 66. No further blood in urine.  As of 5/8/12, rash continues to recurr with exercise, though less frequently now.
swollen lymph nodes underneath her arm pits, collar bone and groin area; This is a spontaneous report from a  contactable pharmacist. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection), via an unspecified route of administration on unspecified date as dose 2, single for COVID-19 immunization. The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: solution for injection), via an unspecified route of administration on unspecified date as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications was not reported. The caller is a pharmacist calling from (pharmacy name) in (State name). She was calling about a patient who received the second dose of the Pfizer Covid vaccine. A couple of days after the second dose, on an unspecified date, the patient had noticed swollen lymph nodes underneath her arm pits, collar bone and in her groin area. The pharmacist said that she was aware of the collar bone and arm pits being swollen that may come with the vaccine but never heard of groin lymph nodes getting swollen. The outcome for the event was unknown.  Follow-up activities closed. Batch/lot number not available for [Vaccine, BNT162B2].
patient returned to store with a very enlarged lower lip on 6/2/21 patient reported this started after receiving dose of covid-19 vaccine saying it started on 6/1/21 advised to take Benadryl and if not resolved by end of day to consult doctor attention
About 2 hours after the injection I saw something that looked like a shade (that wasn't really there). It was moving fast, then jumped back to where it started from, repeating the same movement. I have perfect vision, something like this is very unusual for me. I just looked away, stayed inside for the rest of the evening, until I went to bed, the event never happened again. The morning after the shot, when I woke up, I noticed something that looked like a birthmark (except red) on the left side of my neck. It didn't look like a cherry angioma, it looked like a red birthmark. Luckily in a week it faded, then it completely disappeared. Since these symptoms appeared so close to the time of vaccination, were unusual for me, and not listed as side effects on the vaccine fact sheet I was given, I thought I would report them.
shortness of breath; chest pain and tightening; chest pain and tightening; This is a spontaneous report from a contactable nurse (patient's spouse). A 52-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration, administered in deltoid left on 10Aug2021 09:00 (Batch/Lot Number: FC3180) (at age 52-year-old) as dose 1, single for covid-19 immunisation. Medical history included high cholesterol from Jun2021 to an unknown date and gastrooesophageal reflux disease from Jun2021 to an unknown date. Concomitant medication(s) included omeprazole (PRILOSEC); pravastatin sodium; paracetamol (TYLENOL); ibuprofen and multivitamins. There were no other vaccines administered on the same date. The patient had his 1st dose of the vaccine the morning of 10Aug2021 and within a minute, he experienced shortness of breath, chest pain and tightening but went away after 3 minutes. Reporter was asking if patient need to get the 2nd dose of the vaccine. Events did not require a visit to the emergency room nor physician's office. Outcome of the events was recovering. The reporter considered the events medically significant.; Sender's Comments: A contributory role of BNT162B2 to events shortness of breath, chest pain and tightening cannot be excluded based on temporal association and available information. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
At 2 am I was awaken by sudden chest pain, a dull ache in the center of my chest, heart palpitations, dizzy, nausea, light headedness, pain in left arm and chest pain that got worse when laying down.  I went to the hospital because I thought it was a heart attack. EKG and chest x-Ray showed no obvious signs and I was discharged and told to take ibuprofen for pain and follow up with my primary care doctor.
last night her arm was very sore; she became "stressed" over it.; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 30Sep2021 (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: ADVIL [IBUPROFEN] taken for headache. Vaccination history included: Bnt162b2 (Dose:1), for COVID-19 Immunization, reaction(s): "Fatigue", "sore arm"; Bnt162b2 (Dose:2), for COVID-19 Immunization, reaction(s): "Arthralgia", "fatigue", "Myalgia", "sore for several days", "low grade fevers". The following information was reported: STRESS (non-serious) with onset 2021, outcome "unknown", described as "she became "stressed" over it."; PAIN IN EXTREMITY (non-serious) with onset 30Sep2021, outcome "unknown", described as "last night her arm was very sore".  Additional information included: The patient stated it seemed that after her booster dose she was had very similar symptoms she had after her 2nd dose.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Body ache, chills, swollen lymph nodes in neck and armpit, headache, sore throat
Patient almost immediately experience tachycardia (98-101), nausea, weakness, feeling of feverish Outcome: Called EMS, pt denied transport, husband will drive pt to the ER. Patient seen in ED and released. Given IV fluids and Zofran.
Rheumatoid Arthritis; she is not showing that she has any antibodies; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (Pfizer-BioNTech COVID-19 vaccine), via an unspecified route of administration on 27Feb2021 (lot number and expiry date was not reported) as dose 2, single for COVID-19 immunization. The patient's medical history was not reported. Concomitant medication included methotrexate (manufacturer unknown) taken for an unspecified indication, start and stop date were not reported. The patient previously received the first dose of BNT162B2 on 06Feb2021 for COVID-19 immunization and had no reaction on previous exposure to vaccine. It was reported that the patient has rheumatoid arthritis since an unknown date and had a Rituxin infusion on 25Mar2021, and then again 2 weeks later. The patient reported that she is not showing that she has any antibodies in 2021. She wanted to know why she got a negative antibody test. The patient also wanted to know if Pfizer has already provided as statement on the need for a booster dose (3rd dose). The outcome of the events was unknown.   Information on the lot/batch number has been requested.
pt devel rash on trunk w/in 48 hrs of vax; tx w/ Atarax;
One or two hours after the vaccination the patient said she started to fell quite tired.  I called her back a couple of times to see how she was doing and she says she is a lot better. She is also pregnant, so I do  not know if this is related to pregnancy or vaccine.
T78.40XA ALLERGIC REACTION, INIT 3/2023 NORMAL DELIVERY
Initial case received on 14 April 2010 from a healthcare professional. A 20 year old female patient received an injection of YF VAX (lot number unknown), oral dose of TYPHOID (manufacturer and lot unknown) and HEP A (manufacturer and lot unknown) on 02 April 2010. She experienced a full body rash 3 days post vaccinations on 05 April 2010. The patient had no pre-existing medical conditions, no known allergies and no illness at the time of the vaccinations. She had no adverse events following prior vaccinations. At the time of the report the patient had not recovered. Follow-up received from a health care provider on 24 May 2010 reported the lot number for the YF VAX vaccine was UF644AA and the lot number for the typhoid vaccine was 3001749. The patient did not receive hepatitis A vaccine. She had no illness at the time of vaccination. The patient had a rash for approximately one month and the rash resolved after being on a prednisone burst. This case had been upgraded to serious. Documents held by sender: None.
Patient received the pfizer vaccine first dose. I asked patient stay after for 15 minutes so he did, but he wander around the vitamin aisle, and he stated he suddenly felt dizzy and he fell over on the floor. I helped patient up and he sat on a chair and he stated he felt cold and was shaking. This all happens within 10 minutes after giving him the vaccine. After about 15  minutes, patient began to return back to normal and he stated he was fine without needing to go to hospital.
This is a spontaneous report from a contactable nurse via a Pfizer sales representative. A patient of unspecified age and gender started to receive PREVNAR 13, via an unspecified route of administration on an unspecified date at a single dose for immunization. The patient's medical history and concomitant medications were not reported. The patient experienced pain at injection site on an unspecified date. Outcome of the event was unknown.
Returned to office 1 1/2 hour after receiving flu shot. States severe itching of hands and feet, cough, choking sensation. Administered Epi 0.3 ml subq.
Case Completed primary Covid series in March 2021, then died of Covid in January 2022. Case sought medical care for cough, respiratory symptoms, fever and chills at local ER on 1/14/2022, but left Against Medical Advise the same day.  He died somewhere out of the facility, where the coroner's report included that Covid contributed to his death on 1/16/2022.
Dizziness (vertigo), it slowly resolves. Treatment: rest, more water intake & over the counters medication to help with the dizziness.
12/12/21 pt had a positive COVID test in Health and Rehab Center; cough; not SOB initially; breathing became labored with O2 sat of 88% on RA; placed on 2L O2 via NC; sent to ED then returned back to facility on the same day; family desired to transition pt to palliative care; over time, pt began to not eat, drink, or take meds; zinc and dexamethasone ordered for pt, but unable to swallow meds; pt continued to decline and passed away in the facility.
Arm tenderness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm tenderness) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A and 027L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On 03-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PAIN IN EXTREMITY (Arm tenderness). At the time of the report, PAIN IN EXTREMITY (Arm tenderness) outcome was unknown.       Concomitant product use was not reported.  Treatment information was not provided.
Arm Pain, Shoulder Pain; Shoulder Dysfunction. Limited Range of Motion Shoulder. Tendonitis. I seeked med attn. 10-1 Prednisone.
I suffer from major depressive disorder already, but after the first vaccine, I had the worst relapse I've ever had, 18 days after word.  I was recovering, then I had the second dose on March 24. Thirteen days later (April 6, 2021), I had another severe relapse that prevented me from being able to work for a eek.
Patient reports having a seizure at 2am the day after vaccination. States it lasted about 2 hours and the next day he was unable to balance and lost vision in one of his eyes. A day later he reports that he returned to normal health.
1/8 itching all over/cough 1/10 difficulty swallowing, unable to feel back of tongue
Patient came for second dose of covid vaccine. Shortly after receiving the vaccine.  Patient reported of having tingling of hands and swelling of tongue.  Pharmacist gave patient a dose of 0.3mg EpiPen injection and call 911. Patient was alert and able to talk.  Patient went with paramedics to the hospital to get checked out.
within 20 hours developed pain in left knee which increased in severity with swelling to the point I could not walk spoke to pharmacist who thought this was a reaction to the high dose flue vaccine, spoke to my orthopedic surgeon who also felt this was a reaction to the high dose flu vaccine
From receiving the injection I had an onset of a headache immediately, the headache lasted for over a week, I could only lift my arm at a 90 degree angle and was fatigued because I was getting no sleep because of the headache, I ended up in both urgent care and the emergency room where they provided a cocktail of medications to try to help alleviate the headache
Staff reported pt in his room with elevated temperature and respiration rate. Two nurses of the day responded, arrived in unit and found pt in care of unit staff, pt laying on his left side on bed and awake and alert. Pt c/o ?feeling terrible, they gave me so many meds?. Temp of 102. Attempted blood sugar check and pt refused. Ortho VS completed, no orthostatic hypotension to note. Pt weak to lower extremities and unsteady when standing. Pt also c/o 10/10 HA. COVID booster, administered 9-29-22. Physician on call notified and downgraded incident to urgent. Unit MD notified and will assess pt in unit. Pt given prn Celecoxib 100mg for HA. Evaluated by PCP and pt placed on Q15 medical at 1428.
Pain in upper arm, progressively getting worse. Trouble sleeping, raising arm, reaching. Also caring Grandchild.
p/vax raised red rash appeared on rt forearm; next 5days red rash appeared on both arms, cheek & rt shoulder; pt fussy; poor sleeping; mom used cortisone cream on rash
Patient received 2nd dose of vaccine on 07/28/21. Started having symptoms the next day. Nausea, elevated blood sugars (type 1 diabetic), diaphoresis
Patient received his second dose of the moderna vaccine for COVID on March 2nd, 2021. Around March 16th, the patient started to feel extreme itching on the lower legs, a few days later, some red, ulcerating nodules began to form. He was initially treated for eczema and prurigo nodularis. The patient has a total of 11 lesions on the right and left shins. He had a biopsy in Aug 2021 with me which showed squamous cell carcinoma, likely keratoacanthoma subtype. I have been treating the patient with intralesional 5-Fluorouracil with significant improvement.